OKLAHOMA CITY, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Graymark Healthcare, Inc. (OTC Markets: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), will hold a conference call on Tuesday, November 13, 2012 at 4:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2012. The financial results are expected to be reported in a press release prior to the call.
Graymark's CEO Stanton Nelson, along with COO, Daryl Royer and CFO, Mark Kidd will host the conference call, followed by a question and answer period.
Date: Tuesday, November 13, 2012
Time: 4:30 p.m. Eastern time.
Dial-In Number: (877) 303-7611 International (970) 315-0445 Conference ID # 69817455
The conference call will be broadcast live at Company's website at www.graymarkhealthcare.com. In addition, the replay will be available after the call at same website link above.
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Genesis Select at 303-415-0200.
About Graymark Healthcare
Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (OTC Markets: GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 107 sleep laboratories primarily in the Midwest, including standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements. For more information, visit www.graymarkhealthcare.com.
Important Cautions Regarding Forward-Looking Statements
This press release contains forward-looking statements that are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the risk that the transaction does not close as planned or at all, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Company Contact: Graymark Healthcare, Inc. Stanton Nelson Chief Executive Officer Tel 405-601-5300 Investor Relations: Genesis Select Kim Rogers-Carrete Tel 303-415-0200 email@example.comSource:Graymark Healthcare, Inc.